International Journal of Hypertension
Volume 2019 (2019), Article ID 9473182, 9 pages
https://doi.org/10.1155/2019/9473182

Research Article

Association between Age at Menarche and Hypertension among Females in Southern China: A Cross-Sectional Study

Wei Zhou,¹ Tao Wang,¹ Lingjuan Zhu,¹ Minghua Wen,² Lihua Hu,² Xiao Huang,² Chunjiao You,² Juxiang Li,² Yanqing Wu,² Qinghua Wu,² Huihui Bao,² and Xiaoshu Cheng²

¹Center for Prevention and Treatment of Cardiovascular Diseases, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China
²Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China

Correspondence should be addressed to Huihui Bao; huihui_bao77@126.com and Xiaoshu Cheng; xiaoshumenfan126@163.com

Received 4 July 2019; Revised 4 September 2019; Accepted 12 September 2019; Published 3 November 2019

Academic Editor: Kwok Leung Ong

Copyright © 2019 Wei Zhou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Background. Association between age at menarche (AAM) and hypertension remains a controversial topic, and data in China were sparse. Therefore, we aimed to investigate the association between AAM and hypertension in Chinese female population. Methods. In this cross-sectional study, 5,102 females aged ≥15 years were enrolled. Self-reported AAM was assessed by the questionnaire. Multiple linear regression analysis was used to evaluate the association between systolic blood pressure (SBP), diastolic blood pressure (DBP), and AAM. Logistic regression analysis was performed to evaluate the association between hypertension and AAM. Generalized additive model (GAM) and smooth curve fitting (penalized spline method) were conducted to explore the exact shape of curve between them. Results. The overall mean of AAM was 15.5 years. Each additional year of AAM was associated with a 15% higher risk of hypertension (odds ratio (OR) = 1.15, 95% confidence interval (CI): 1.11–1.19). Among females with hypertension, there was a significant positive association between AAM and SBP (β = 0.88, 95% CI: 0.29–1.46) and DBP (β = 0.80, 95% CI: 0.47–1.13). A significantly higher risk of hypertension was found in younger subjects (15–44 y: OR = 1.37, 95% CI: 1.21–1.55; for interaction = 0.009) compared with those aged between 62 and 97 y.Conclusions. AAM was positively associated with hypertension and blood pressure, especially among females in early adulthood from southern China.

1. Introduction

AAM is the onset of the first menstrual cycle, which represents the beginning of the capacity to reproduce, and can influence the health in later life of females [1]. Previous researches have shown that an early AAM was linked to increase the risk of type 2 diabetes [2, 3], obesity [4, 5], metabolic syndrome [6], cardiovascular diseases (CVD), and all-cause mortality in the later adult life [7]. Although growing evidence has established the association of AAM with hypertension, conflicting results could be found among those reports. Canoy et al. [7] reported that there was a U-shaped pattern of relationship between AAM and hypertension in UK female population. For females with AAM up to 13 years, the risk of hypertension reduced as AAM increased, whereas, for those with AAM over 13 years, the risk of hypertension increased with AAM. Compared with AAM at 13 years, AAM at ≤10 and ≥17 years was significantly associated with increased relative risks (and 95% CIs) of 1.14 (1.12–1.16) and 1.08 (1.04–1.11) for hypertension. Previous studies found that an early AAM was related to higher blood pressure (BP) and hypertension, in China, Korea, Singapore, or western countries [8–11]. However, Liu et al. [12] revealed that females with late menarche had a higher risk of hypertension in southwestern China. Moreover, the nonlinearity of AAM and hypertension was rarely analyzed. We hypothesized that the association between AAM and hypertension might vary among ethnic groups, and there might be a nonlinear relationship between them. Therefore, we investigated AAM and hypertension in Chinese females.

2. Methods

2.1. Ethics Statement

Ethical approval was obtained from the ethics review boards of the Second Affiliated Hospital of Nanchang University and the Fuwai Cardiovascular Hospital (Beijing, China). All participants who wrote informed consent were enrolled in the study. If the participants were unable to write, fingerprinting was used. The ethics committee approved the procedure.

2.2. Study Population

We followed the methods of Yu et al. [13], and all investigators were not aware of the hypothesis. Using a stratified multistage random sampling method, a total of 15,364 eligible participants aged ≥15 years were enrolled in our study, and 15,296 of them completed the assessment from November 2013 to August 2014. After excluding males and participants with missing data for AAM and BP/hypertension , a total of 5102 participants were included in the final analysis (Figure 1).

Figure 1: Flow chart of study participants.

2.3. Questionnaire Survey

Participants were required to finish a standardized questionnaire which was developed by the national coordinating center of Fuwai Cardiovascular Hospital (Beijing, China) through face-to-face interviews. The questionnaire included demographic information (such as age, gender, residence marital status, and education), behavioral characteristics (including smoking, drinking, physical activity, and sleeping duration), and medical history (hypertension, MI, and stroke, which were collected and verified with medical or hospital records). The survey staff received training on data collection before the survey.

2.4. Physical Examination

Weight was measured using an Omron body fat and weight measurement device (V-BODY HBF-371; Omron, Kyoto, Japan) to the nearest 0.01 kg in light clothing without shoes indoors. Height was measured without shoes using a standard right-angle device and a fixed vertical ruler to the nearest 0.1 cm. Waist circumference (WC) was obtained by a measuring tape to the nearest 0.1 cm as the minimum circumference at the midpoint between the costal margin and iliac crests (at the level of umbilicus) in light clothing. Body fat percentage (BFP), visceral adiposity index (VAI), and basal metabolic rate (BMR) were also measured using an Omron body fat and weight measurement device (V-BODY HBF-371; Omron, Kyoto, Japan). All measurements were taken twice, and the average of the 2 values was used. Systolic BP (SBP), diastolic BP (DBP), and heart rate (HR) were measured 3 times on the right arm positioned at the heart level with an electronic BP monitor (Omron HBP-1300; OMRON, Kyoto, Japan) after a rest for 5 minutes, with a 30-second interval between each measurement, and the average value of 3 readings was used for analysis [14]. Participants were asked to avoid vigorous exercise, smoking, drinking, and consumption of coffee and tea for at least 30 minutes before the measurements.

2.5. Definitions

AAM was defined as the age in whole years at the first menstrual period. Age at menopause was the age in whole years at the last menstrual period, whether natural or resulting from hysterectomy or ovariectomy. Hypertension was defined as previously diagnosed hypertension with or without current treatment or the average SBP ≥ 140 mmHg and/or DBP ≥ 90 mmHg at physical examinations [15, 16]. Body mass index (BMI) was calculated as the weight (kg)/height (m²) and classified into groups of <18.5, 18.5–23.9, 24.0–27.9, and ≥28.0 kg/m². Education level was divided into 3 domains according to the number of years of education (0 to 6, 7 to 9, and ≥10 years). Alcohol drinking was defined as drinking alcohol at least one time per week during the previous year. Smoking was defined as never, current (daily smoking, >6 months), and former (cessation of smoking, >6 months) [17–19]. Physical activity was assessed and classified by the International Physical Activity Questionnaire (IPAQ), which was supported by the WHO and the Centers for Disease Control (CDC) [20, 21]. Each individual was grouped as performing low, moderate, or vigorous physical activity, according to the questionnaire scoring protocol (standard scoring criteria at http://www.ipaq.ki.se). Sleep duration was based on the response to the questions: “How many hours of sleep do you get in a 24-hour period on a weekday and nonworkday, respectively? ” The weighted average of the weekly sleep duration was calculated by using the formula: (sleep duration on weekdays ×5 + sleep duration on the weekend ×2)/7 [22].

2.6. Statistical Analysis

Continuous variables were presented as the means (standard deviation, SD) or medians (interquartile range), and categorical variables were expressed as percentages among the overall subjects and by AAM stratified into ≤13, 14-15, 16-17, and ≥18 years. Continuous variables were checked for normality and were logtransformed, if necessary. Categorical variables were analyzed using the chi-square test, and continuous variables were analyzed by one-way analysis of variance (ANOVA). Multiple linear regression analysis was carried out to evaluate β and 95% CIs between SBP, DBP, and AAM. Multivariate binary logistic regression was performed to evaluate the odds ratio (ORs) and 95% CIs of hypertension being associated with AAM. We built three sets of models based on clinical experiences and literatures. Crude model controlled for none. Model 1 controlled for age, residence, education, and marital status. Model 2 controlled for all variables in model 2 plus smoking, drinking, menopause, antihypertensive medication, physical activity, BMI, WC, BFP, VAI, BMR, HR, and sleeping duration. Multicollinearity was checked among all covariates included in model 2, and none of variables violated the criteria. Subgroup analysis by age, education, marital status, smoking, drinking, menopause, physical activity, and BMI was conducted to test for interactions between AAM and the potential confounders by including cross-product interaction terms in the corresponding multiple linear regression models. Moreover, to explore the nonlinear relationship between AAM and hypertension, a generalized additive model (GAM) and smooth curve fitting (penalized spline method) were conducted. All tests of statistical significance were based on . All analyses were done with Empower (R) (https://www.empowerstats.com; X&Y Solutions, Inc, Boston, MA), and the forest plot was generated by R software, version 3.1.2 (http://www.r-project.org).

3. Results

3.1. Characteristics of Subjects

As shown in Table 1, a total of 5102 females (aged from 15 to 97 years, with a mean of 52.6 years at enrollment) were included in this study. The mean of AAM (aged from 9 to 24 years) for the total sample was 15.5 years. The overall prevalence of hypertension was 29.3% in our study. Compared with females with early AAM, females with a later AAM were more likely to have a larger mean enrollment age, BMI, WC, and also a higher BFP, VAI, SBP, DBP, prevalence of hypertension, rate of antihypertension medication, and menopause, and tended to engage in more vigorous physical activity (all ). Females with an earlier AAM were tended to be unmarried and engaged in more low or moderate physical activity. In addition, 2700 out of 5102 were postmenopausal females, and their mean ages at menopause (SD) across AAM categories (≤13, 14-15, 16-17, and ≥18 years) were, respectively, 48.0 (6.3), 47.9 (5.1), 48.5 (6.8), and 48.2 (5.5) with no significant difference .

Table 1: Baseline characteristics according to age at menarche.

Characteristics
Overall
Age at menarche, y
value

≤13
14-15
16-17
≥18

(%)
5,102
869
1,749
1,578
906
—

Enrollment age, y, mean (SD)
52.6 (17.7)
50.6 (18.5)
52.6 (17.6)
53.2 (17.5)
53.2 (17.5)
0.003

Age at menarche, y, mean (SD)
15.5 (2.1)
12.6 (0.7)
14.5 (0.5)
16.4 (0.5)
18.7 (1.0)
<0.001

Menopause,
2700 (52.92%)
276 (31.76%)
815 (46.60%)
956 (60.58%)
653 (72.08%)
<0.001

Hypertension,
1,495 (29.3%)
204 (23.5%)
427 (24.4%)
538 (34.1%)
326 (36.0%)
<0.001

Antihypertensive medication,
375 (7.4%)
58 (6.7%)
101 (5.8%)
141 (8.9%)
75 (8.3%)
0.003

Residence (urban),
2528 (49.6%)
430 (49.5%)
871 (49.8%)
803 (50.9%)
424 (46.8%)
0.271

Education, y,

0.370

0–6
2848 (55.8%)
464 (53.4%)
961 (54.9%)
905 (57.4%)
518 (57.2%)

7–9
1136 (22.3%)
196 (22.6%)
394 (22.5%)
352 (22.3%)
194 (21.4%)

≥10
1118 (21.9%)
209 (24.1%)
394 (22.5%)
321 (20.3%)
194 (21.4%)

Marital status,

0.033

Unmarried
502 (9.8%)
112 (12.9%)
175 (10.0%)
138 (8.8%)
77 (8.5%)

Married
3915 (76.7%)
648 (74.6%)
1332 (76.2%)
1231 (78.0%)
704 (77.7%)

Divorced or widowed
685 (13.5%)
109 (12.5%)
242 (13.8%)
209 (13.2%)
125 (13.8%)

Smoking,

0.860

Never
5023 (98.4%)
854 (98.3%)
1724 (98.5%)
1550 (98.2%)
895 (98.8%)

Current
70 (1.4%)
13 (1.5%)
22 (1.3%)
26 (1.7%)
9 (1.0%)

Former
9 (0.2%)
2 (0.2%)
3 (0.2%)
2 (0.1%)
2 (0.2%)

Drinking,
727 (14.3%)
119 (13.7%)
245 (14.0%)
231 (14.6%)
132 (14.6%)
0.902

Physical activity,

0.008

Low
660 (12.9%)
117 (13.5%)
215 (12.3%)
180 (11.4%)
148 (16.3%)

Moderate
1495 (29.3%)
265 (30.5%)
534 (30.5%)
457 (29.0%)
239 (26.4%)

Vigorous
2947 (57.8%)
487 (56.0%)
1000 (57.2%)
941 (59.6%)
519 (57.3%)

BMI, kg/m², mean (SD)
22.8 (3.6)
22.4 (3.3)
22.84 (3.6)
23.0 (3.7)
22.9 (3.6)
<0.001

WC, cm, mean (SD)
77.8 (9.6)
76.8 (9.6)
77.9 (9.3)
78.2 (9.6)
78.0 (9.8)
0.005

BFP, %, mean (SD)
30.2 (7.7)
29.5 (7.6)
30.1 (8.0)
30.5 (7.4)
30.3 (7.6)
0.035

VAI, mean (SD)
6.3 (3.7)
6.0 (3.4)
6.3 (3.6)
6.5 (3.8)
6.4 (4.0)
0.025

BMR, kcal/day, mean (SD)
1167.9 (312.0)
1153.9 (266.8)
1164.2 (296.3)
1178.9 (366.8)
1169.6 (275.5)
0.265

HR, mean (SD)
78.8 (11.1)
78.4 (10.4)
78.7 (11.0)
78.9 (11.3)
79.1 (11.4)
0.543

SBP, mmHg, mean (SD)
124.7 (21.6)
121.6 (19.1)
122.6 (20.4)
126.5 (22.5)
128.5 (23.5)
<0.001

DBP, mmHg, mean (SD)
72.9 (11.5)
71.2 (8.9)
72.14 (11.0)
73.8 (12.33)
74.7 (12.6)
<0.001

Sleeping duration, h, mean (SD)
7.3 (1.6)
7.3 (1.6)
7.2 (1.6)
7.2 (1.7)
7.2 (1.6)
0.884

BMI = body mass index; BMR = basal metabolism rate; WC = waist circulation; BFP = body fat percentage; VAI = visceral adiposity index; SBP = systolic blood pressure; DBP = diastolic blood pressure; HR = heart rate.

3.2. Association between AAM and Hypertension

Table 2 presents OR and 95% CI for hypertension according to AAM. After adjusting all confounders, per 1 year increase of AAM was associated with 15% increased risk of hypertension . Compared with AAM ≤13 year, ORs (95% CIs) for hypertension across AAM at 14-15, 16-17, and ≥18 years were 0.95(0.76, 1.19), 1.68(1.34, 2.11), and 2.01(1.56, 2.58), respectively ( for trend <0.001). However, there was no significant difference between females with AAM at ≤13 years and 14 to 15 years, so we combined the two AAM groups in Table 2. Compared with females with AAM at ≤15 years, the fully adjusted ORs (95% CIs) for hypertension across AAM at 16-17 and ≥18 years were, respectively, 1.74 (1.48, 2.05) and 2.08 (1.71, 2.53). In the present study, the adjusted smooth curve showed the linear association between AAM and hypertension (Figure 2).

Table 2: Analysis of AAM and hypertension.

AAM

Hypertension OR (95% CI), value

Cases
Crude
Model 1
Model 2

Continuous variable
5,102
1,495
1.13 (1.10, 1.16), <0.001
1.14 (1.10, 1.17), <0.001
1.15 (1.11, 1.19), <0.001

Categorical variables

≤13 y
869
204
1.00
1.00
1.00

14-15 y
1,749
427
1.05 (0.87, 1.27), 0.597
0.97 (0.78, 1.20), 0.765
0.95 (0.76, 1.19), 0.681

16-17 y
1,578
538
1.69 (1.40, 2.04), <0.001
1.65 (1.43, 2.02), <0.001
1.68 (1.34, 2.11), <0.001

≥18 y
906
326
1.83 (1.49, 2.25), <0.001
1.89 (1.50, 2.40), <0.001
2.01 (1.56, 2.58), <0.001

for trend
—
—
<0.001
<0.001
<0.001

≤15 y
2,618
631

16-17 y
1,578
538
1.63 (1.42, 1.87), <0.001
1.68 (1.44, 1.97), <0.001
1.74 (1.48, 2.05), <0.001

≥18 y
906
326
1.77 (1.50, 2.08), <0.001
1.94 (1.61, 2.33), <0.001
2.08 (1.71, 2.53), <0.001

for trend
—
—
<0.001
<0.001
<0.001

Model 1 included enrollment age, residence, education, and marital status for adjustment. Model 2 included enrollment age, residence, education, marital status, smoking, drinking, menopause, antihypertensive medication, physical activity, BMI, WC, BFP, VAI, BMR, HR, and sleeping duration. BMI = body mass index; BMR = basal metabolism rate; WC = waist circulation; BFP = body fat percentage; VAI = visceral adiposity index; HR = heart rate.

Figure 2: Multivariate adjusted smooth curve of hypertension by AAM. The solid line represents the estimated values, and the dashed line represents the 95% CI. Adjusted for enrollment age, residence, education, marital status, smoking, drinking, menopause, antihypertensive medication, physical activity, BMI, WC, BFP, VAI, BMR, HR, and sleeping duration.

3.3. Association between AAM and SBP, DBP

Among hypertensive females, AAM was significantly positively correlated with SBP (β (95% CI) = 0.88 (0.29, 1.46)) and DBP (β (95% CI) = 0.80 (0.47, 1.13)) (Table 3). When AAM was divided into ≤15, 16-17, and ≥18 years, each stratum of AAM was positively associated with SBP and DBP ( for trend <0.001).

Table 3: Analysis of AAM and SBP, and DBP in females with hypertension.

AAM, y

Mean (SD)
β (95% CI), value

Crude
Model 1
Model 2

SBP

Continuous variable, y
1,495
146.9 (24.3)
0.86 (0.28, 1.45), 0.004
0.98 (0.40, 1.56), 0.001
0.88 (0.29, 1.46), 0.003

Categorical variables

≤15 y
631
144.5 (25.6)
0
0
0

16-17 y
538
147.8 (23.0)
3.32 (0.54, 6.10), 0.020
3.72 (0.95, 6.49), 0.009
3.50 (0.72, 6.27), 0.014

≥18 y
326
150.2 (23.3)
5.67 (2.44, 8.90), 0.001
6.41 (3.20, 9.63), <0.001
5.84 (2.62, 9.05), <0.001

for trend
—
—
<0.001
<0.001
<0.001

DBP

Continuous variable
1,495
80.6 (14.4)
0.86 (0.52, 1.21), <0.001
0.88 (0.54, 1.22), <0.001
0.80 (0.47, 1.13), <0.001

Categorical variables

≤15 y
631
78.2 (14.7)
0
0
0

16-17 y
538
82.3 (13.9)
4.07 (2.43, 5.71), <0.001
4.09 (2.48, 5.71), <0.001
3.35 (1.81, 4.88), <0.001

≥18 y
326
82.7 (13.9)
4.50 (2.60, 6.41), <0.001
4.54 (2.66, 6.42), <0.001
4.34 (2.53, 6.16), <0.001

for trend
—
—
<0.001
<0.001
<0.001

Model 1 adjusted for enrollment age, residence, education, and marital status for adjustment. Model 2 adjusted for enrollment age, residence, education, marital status, smoking, drinking, menopause, antihypertensive medication, physical activity, BMI, WC, BFP, VAI, BMR, HR, and sleeping duration. BMI = body mass index; BMR = basal metabolism rate; WC = waist circulation; BFP = body fat percentage; VAI = visceral adiposity index; HR = heart rate.

3.4. Hypertension and AAM by Subgroups

Further subgroup analyses were performed by several important covariables, including age, education, marital status, drinking, smoking, menopause, physical activity, and BMI. Figure 3 shows that, in multivariable-adjusted models, AAM was independently and positively associated with hypertension in all subgroups consistently. However, except the enrollment age subgroup, there were no significant interactions in any other subgroups ( for interaction >0.05). ORs (95% CIs) for hypertension across AAM in three enrollment age subgroups (tertile 1 : 15–44 y, tertile 2 : 45–61 y, and tertile 3 : 62–97 y) were, respectively, 1.37 (1.21–1.55), 1.16 (1.10–1.23), and 1.10 (1.04–1.15), with a decreasing trend ( for interaction = 0.009).

Figure 3: Effect size of AAM on hypertension in each subgroup. Adjusted, if not stratified, for enrollment age, residence, education, marital status, smoking, drinking, menopause, antihypertensive medication, physical activity, BMI, WC, BFP, VAI, BMR, HR, and sleeping duration.

4. Discussion

In our study, we found that AAM was independently and positively associated with SBP and DBP and the prevalence of hypertension. For every 1-year increase in AAM, the risk of hypertension increased by 15% in all females, while SBP and DBP increased by 0.88 and 0.80 mmHg among hypertensive females. The fully adjusted smooth curve fitting presented a linear association between AAM and hypertension. Subgroup analysis showed that stronger associations between AAM and hypertension were detected in young females.

AAM serves as a significant event in the life of female, and the timing for the first menstrual period plays an important role for health of pre- and postmenopausal females [6]. Most of previous studies indicated that AAM was inversely related to hypertension worldwide, including developed Asian regions as well as some Chinese cities [8–11]. A study of 15,807 Caucasian females indicated that females with early menarche (≤12 years) had a higher risk of hypertension (OR = 1.13, 95% CI: 1.02–1.24) [8]. This study was consistent with a study of 6,242 females (21–92-year-old) as they showed that later menarche (≥18 years) was significantly correlated with lower hypertension risk (OR = 0.71, 95% CI: 0.57–0.89) [23]. A retrospective study of 13,242 subjects conducted in Chinese cities of Beijing and Xiaogan revealed that later AAM was associated with an increased risk for self-reported hypertension [24]. A study among 7,119 females from southern China reported that females with a late AAM (≥18 years) had a 39% increased risk of hypertension [12]. However, some papers had rather weak conclusions about the association between AAM and hypertension. A previous literature review on reproductive risk factors and CVD in postmenopausal females concluded that AAM had no statistically significant association with hypertension [25]. In addition, a recent study among 6,252 Chinese females from Henan Province in central China showed that females with older AAM had a higher risk of hypertension, but the association was not statistically significant [26]. Our study contributed a further evidence that late AAM increased SBP and DBP and the risk of hypertension in Chinese female population. According to the existing results, AAM was positively associated with hypertension mainly in Chinese females. The possible reasons contributing to the discrepancy included different race backgrounds, lifestyle behaviors, and living conditions between the two study populations [27, 28].

A previous cohort study reported that obesity, smoking, low physical activity, and BP increased with the time of AAM, but they interacted very weakly. In addition, educational qualifications of “college or above” were associated with later menarche [29, 30]. Lakshman et al. [8] concluded that the association between AAM and hypertension was partly mediated by adiposity. Mueller et al. [10] investigated in a large number of Chinese females in Singapore and found that a potential AAM-smoking interaction in correlation with CVD risk. In subgroup analysis, we found that the associations between AAM and hypertension were consistent in the following subgroups: education, marital status, smoking, drinking, menopause, physical activity, and BMI, whereas a stronger association between AAM and hypertension was detected in females aged 15–44 years than those aged 45 years or above. It suggests that if a female had a later AAM, she should monitor her blood pressure in their young adulthood.

According to previous studies, AAM among females in Belgium, Hungary, Britain, USA, and Scandinavia were steadily at around 13.0 ± 0.5 years [31], while the overall Chinese level of AAM was at 12.4 years in 2012 [32]. Compared with other female populations, the average AAM (15.5 years) among females in our study was 2.5 to 3.1 years later. The menarche timing was determined by genetic, living environment factors, and physical condition [33, 34]. Our study’ participants were from Jiangxi Province, an underdeveloped region in southern China, where they had a low income and poor living conditions in the past. A late menarche might be due to poor nutrition in their early life, which might subsequently result in a higher risk of hypertension in late life [35]. In addition, during the years from menarche to menopause (reproductive time), females of reproductive age were continuously in estrogen exposure. Estrogen would protect females in the reproductive stage from cardiovascular diseases [25]. In our study, there were no significant differences among average age at menopause across AAM categories (≤13, 14-15, 16-17, and ≥18 years) for 2700 postmenopausal females, which meant females with a later AAM experienced shorter reproductive time. A previous study [12] on 7,119 southwestern Chinese females reported a similar conclusion. This perhaps led to an increased risk of CVD, such as hypertension [36, 37]. Moreover, our findings revealed that females with later AAM had a larger BMI, WC, BFP, and VAI during adulthood, with the similar conclusion reported in a large population-based investigation [22]. People with high levels of these physical indicators were prone to obesity. As previously reported, overweight/obesity was one of the strongest proximal risk factors of hypertension [38, 39]. In summary, the possible explanation for our finding is that a later AAM was associated with a higher risk of hypertension, mainly including poor nutrition in early life, menstruation delay, short reproductive period, different races, and lifestyle habits.

This study has some limitations. First, as a cross-sectional survey, our study could not provide the causal relationship between AAM and hypertension. Second, participants in the present study were enrolled from Jiangxi Province in southern China; therefore, the generalizability of conclusions to other regions remains to be verified. Third, AAM and some covariables were obtained according to the self-reported questionnaire responses, which might exist a bias. Finally, although we considered influence factors as many as possible, maybe other potential confounding factors were still not be included. Our study has several strengths. It was the first time to explore the exact shape of curve between AAM and hypertension among females in a developing country. All participants were randomly recruited based on city-sex-age distribution, and the representativeness of sample was better than that based on hospital data. Moreover, the information in our study was collected by face-to-face interviews, which is more reliable than telephone interviews.

5. Conclusion

In conclusion, our findings demonstrated that a late menarche was associated with a high BP and risk of hypertension in southern China, especially in young females. This association was independent of demographics and other risk factors. These findings indicated that knowledge of AAM could be regarded as a preventive marker for identifying females at risk of hypertension. In addition, further longitudinal epidemiological researches are needed to evaluate the effects between AAM and hypertension.

Data Availability

The data used to support the findings of this study are available from the corresponding author upon request.

Conflicts of Interest

The authors declare that there are no conflicts of interest regarding the publication of this paper.

Authors’ Contributions

Xiaoshu Cheng and Huihui Bao designed this study. Wei Zhou and Tao Wang drafted the manuscript. Huihui Bao and Wei Zhou revised the manuscript. All authors read and approved the final manuscript. Lihua Hu, Xiao Huang, and Chunjiao You took part in the whole investigation. Lingjuan Zhu, Minghua Wen, and Wei Zhou analyzed the data. Juxiang Li, Yanqing Wu, and Qinghua Wu supervised the investigation process.

Acknowledgments

All authors acknowledge the study participants and the study staff members who contributed in this study and appreciate the help of the local health bureau. This study was supported by the Major New Drug Creation Program from National Science and Technology Major Project (2014ZX09303305), National Natural Science Foundation of China (81960074 and 81500233), Science and Technology Planning Project of Jiangxi Province (20161ACG70012), Key Project of Jiangxi Provincial Education Department (GJJ170013), Natural Science Foundation of Jiangxi Province (20192BAB205033), Science and Technology Plan of Health Commission of Jiangxi Province (20172329), Jiangxi Outstanding Person Foundation (20192BCBL23024), and Major projects of the Science and Technology Department, Jiangxi (20171BAB205008).

References

J. E. Luján Irastorza, F. García Rodríguez, G. Figueroa Preciado, I. Hernández Marín, and A. R. Ayala, “Early menarche as a risk factor of breast cancer,” Ginecologia y Obstetricia de Mexico, vol. 74, no. 11, pp. 568–572, 2006.

C. He, C. Zhang, D. J. Hunter et al., “Age at menarche and risk of type 2 diabetes: results from 2 large prospective cohort studies,” American Journal of Epidemiology, vol. 171, no. 3, pp. 334–344, 2010.

D. Stöckl, A. Döring, A. Peters et al., “Age at menarche is associated with prediabetes and diabetes in women (aged 32–81 years) from the general population: the KORA F4 study,” Diabetologia, vol. 55, no. 3, pp. 681–688, 2012.

I. Bralic, H. Tahirovic, D. Matanic et al., “Association of early AAM and overweight/obesity,” Journal of Pediatric Endocrinology & Metabolism, vol. 25, no. 1-2, pp. 57–62, 2012.

P. Prentice and R. M. Viner, “Pubertal timing and adult obesity and cardiometabolic risk in women and men: a systematic review and meta-analysis,” International Journal of Obesity, vol. 37, no. 8, pp. 1036–1043, 2013.

C. J. Glueck, J. A. Morrison, P. Wang, and J. G. Woo, “Early and late menarche are associated with oligomenorrhea and predict metabolic syndrome 26 years later,” Metabolism, vol. 62, no. 11, pp. 1597–1606, 2013.

D. Canoy, V. Beral, A. Balkwill et al., “Age at menarche and risks of coronary heart and other vascular diseases in a large UK cohort,” Circulation, vol. 131, no. 3, pp. 237–244, 2015.

R. Lakshman, N. G. Forouhi, S. J. Sharp et al., “Early age at menarche associated with cardiovascular disease and mortality,” Journal of Clinical Endocrinology & Metabolism, vol. 94, no. 12, pp. 4953–4960, 2009.

M. Heys, C. M. Schooling, C. Jiang et al., “Age of menarche and the metabolic syndrome in China,” Epidemiology, vol. 18, no. 6, pp. 740–746, 2007.

N. T. Mueller, A. O. Odegaard, M. D. Gross, W. P. Koh, J.-M. Yuan, and M. A. Pereira, “Age at menarche and cardiovascular disease mortality in Singaporean Chinese women: the Singapore Chinese health study,” Annals of Epidemiology, vol. 22, no. 10, pp. 717–722, 2012.

J. C. Won, J. W. Hong, J. H. Noh, and D.-J. Kim, “Association between age at menarche and risk factors for cardiovascular diseases in Korean women: the 2010 to 2013 Korea National Health and Nutrition Examination Survey,” Medicine (Baltimore), vol. 95, no. 18, p. e3580, 2016.

G. Liu, Y. Yang, W. Huang et al., “Association of age at menarche with obesity and hypertension among southwestern Chinese women: a new finding,” Menopause, vol. 25, no. 5, pp. 546–553, 2017.

L. Yu, Q. Liang, W. Zhou et al., “Sedentary behavior and the risk of cardiac-cerebral vascular diseases in southern China,” Medicine, vol. 97, no. 44, p. e12838, 2018.

Z. W. Wang, Z. Chen, L. F. Zhang et al., “Status of hypertension in China: results from the China hypertension survey, 2012–2015,” Circulation, vol. 137, no. 22, pp. 2344–2356, 2018.

A. Gambelunghe, G. Sallsten, Y. Borné et al., “Low-level exposure to lead, blood pressure, and hypertension in a population-based cohort,” Environmental Research, vol. 149, pp. 157–163, 2016.

K. B. Fuks, G. Weinmayr, F. Hennig et al., “Association of long-term exposure to local industry- and traffic-specific particulate matter with arterial blood pressure and incident hypertension,” International Journal of Hygiene and Environmental Health, vol. 219, no. 6, pp. 527–535, 2016.

C. Wang, W. Li, L. Yin et al., “Comparison of healthy lifestyle behaviors among individuals with and without cardiovascular diseases from urban and rural areas in China: a cross-sectional study,” PLoS One, vol. 12, no. 8, Article ID e0181981, 2017.

GBD 2015 Risk Factors Collaborators, “Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015,” The Lancet, vol. 388, no. 10053, pp. 1659–1724, 2016.

Y. Je, I. DeVivo, and E. Giovannucci, “Long-term alcohol intake and risk of endometrial cancer in the Nurses’ Health Study, 1980–2010,” British Journal of Cancer, vol. 111, no. 1, pp. 186–194, 2014.

A. Bauman, F. Bull, T. Chey et al., “The international prevalence study on physical activity: results from 20 countries,” International Journal of Behavioral Nutrition and Physical Activity, vol. 6, no. 1, p. 21, 2009.

W. L. Haskell, I. M. Lee, R. R. Pate et al., “Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association,” Circulation, vol. 116, no. 9, pp. 1081–1093, 2007.

A. P. Kong, Y.-K. Wing, K. C. Choi et al., “Associations of sleep duration with obesity and serum lipid profile in children and adolescents,” Sleep Medicine, vol. 12, no. 7, pp. 659–665, 2011.

C. Qiu, H. Chen, J. Wen et al., “Associations between age at menarche and menopause with cardiovascular disease, diabetes, and osteoporosis in Chinese women,” Journal of Clinical Endocrinology & Metabolism, vol. 98, no. 4, pp. 1612–1621, 2013.

Y. Zheng, G. Zhang, Z. Chen, and Q. Zeng, “Association between age at menarche and cardiovascular disease risk factors in China: a large population-based investigation,” Cardiorenal Medicine, vol. 6, no. 4, pp. 307–316, 2016.

M. J. J. de Kleijn, Y. T. van der Schouw, and Y. van der Graaf, “Reproductive history and cardiovascular disease risk in postmenopausal women: a review of the literature,” Maturitas, vol. 33, no. 1, pp. 7–36, 1999.

Q. Yang, C. Song, J. Jiang et al., “Association of reproductive history with hypertension and prehypertension in Chinese postmenopausal women: a population-based cross-sectional study,” Hypertension Research, vol. 41, no. 1, pp. 66–74, 2018.

W. C. Chumlea, C. M. Schubert, A. F. Roche et al., “Age at menarche and racial comparisons in US girls,” Pediatrics, vol. 111, no. 1, pp. 110–113, 2003.

P. B. Reagan, P. J. Salsberry, M. Z. Fang, W. P. Gardner, and K. Pajer, “African-American/white differences in the age of menarche: accounting for the difference,” Social Science & Medicine, vol. 75, no. 7, pp. 1263–1270, 2012.

R. Gupta, V. P. Gupta, and N. S. Ahluwalia, “Educational status, coronary heart disease, and coronary risk factor prevalence in a rural population of India,” BMJ, vol. 309, no. 6965, pp. 1332–1336, 1999.

K. Liu, L. B. Cedres, J. Stamler et al., “Relationship of education to major risk factors and death from coronary heart disease, cardiovascular diseases and all causes, Findings of three Chicago epidemiologic studies,” Circulation, vol. 66, no. 6, pp. 1308–1314, 1982.

L. Lalys and J.-C. Pineau, “Age at menarche in a group of French schoolgirls,” Pediatrics International, vol. 56, no. 4, pp. 601–604, 2014.

Y. Sun, F.-B. Tao, P.-Y. Su et al., “National estimates of the pubertal milestones among urban and rural Chinese girls,” Journal of Adolescent Health, vol. 51, no. 3, pp. 279–284, 2012.

S. Jahanfar, M. S. Lye, and I. S. Krishnarajah, “Genetic and environmental effects on age at menarche, and its relationship with reproductive health in twins,” Indian Journal of Human Genetics, vol. 19, no. 2, pp. 245–250, 2013.

M. Rees, “The age of menarche,” Orgyn, vol. 4, pp. 2–4, 1995.

L. Shen, L. Wang, Y. Hu et al., “Associations of the ages at menarche and menopause with blood pressure and hypertension among middle-aged and older Chinese women: a cross-sectional analysis of the baseline data of the China Health and Retirement Longitudinal Study,” Hypertension Research, vol. 42, no. 5, pp. 730–738, 2019.

K. J. Jung, M.-R. Kim, Y. D. Yun, H. C. Kim, and S. H. Jee, “Duration of ovarian hormone exposure and atherosclerotic cardiovascular disease in Korean women,” Menopause, vol. 23, no. 1, pp. 60–66, 2016.

Y.-C. Hsieh, L.-C. Hwang, F.-I. Hsieh et al., “Early menarche and ischemic stroke risk among postmenopausal women,” International Journal of Gerontology, vol. 4, no. 1, pp. 16–22, 2010.

L. Gnatiuc, J. Alegre-Díaz, J. Halsey et al., “Adiposity and blood pressure in 110 000 Mexican adults,” Hypertension, vol. 69, no. 4, pp. 608–614, 2017.

S. R. Shrivastava, P. S. Shrivastava, and J. Ramasamy, “The determinants and scope of public health interventions to tackle the global problem of hypertension,” International Journal of Prevention Medicine, vol. 5, no. 7, pp. 807–812, 2014.